Expert Opin Ther Targets. 2011 Aug;15(8):903-12. doi: 10.1517/14728222.2011.586635. Epub 2011 May 28.
Increasing numbers of proteins, nucleic acids and other molecular entities have been explored as therapeutic targets. A challenge in drug discovery is to decide which targets to pursue from an increasing pool of potential targets, given the fact that few innovative targets have made it to the approval list each year. Knowledge of existing drug targets (both approved and within clinical trials) is highly useful for facilitating target discovery, selection, exploration and tool development. The Therapeutic Target Database (TTD) has been developed and updated to provide information on 358 successful targets, 251 clinical trial targets and 1254 research targets in addition to 1511 approved drugs, 1118 clinical trials drugs and 2331 experimental drugs linked to their primary targets (3257 drugs with available structure data). This review briefly describes the TTD database and illustrates how its data can be explored for facilitating target and drug searches, the study of the mechanism of multi-target drugs and the development of in silico target discovery tools.
越来越多的蛋白质、核酸和其他分子实体已被探索作为治疗靶点。药物发现的一个挑战是,在每年只有少数创新靶点获得批准的情况下,从越来越多的潜在靶点中选择要研究的靶点。了解现有的药物靶点(包括已批准和临床试验中的靶点)对于促进靶点发现、选择、探索和工具开发非常有用。Therapeutic Target Database(TTD)已经开发和更新,提供了 358 个成功靶点、251 个临床试验靶点和 1254 个研究靶点的信息,以及 1511 个已批准药物、1118 个临床试验药物和 2331 个实验药物与其主要靶点的关联(3257 种具有可用结构数据的药物)。本文简要描述了 TTD 数据库,并说明了如何利用其数据来促进靶点和药物搜索、研究多靶点药物的作用机制以及开发基于计算机的靶点发现工具。